21st Century Oncology of Las Vegas Clinical Director, Dr. Brian Lawenda, is in the running for the “Man of the Year” award presented by the Leukemia & Lymphoma Society.

Each year, in communities across the country, dynamic, passionate candidates engage in a spirited competition to earn The Leukemia & Lymphoma Society’s “Man & Woman of the Year” titles, by raising funds for blood cancer research. The candidates compete in honor of children who are local blood cancer survivors, the Boy & Girl of the Year. Every dollar counts as one vote, and the titles are awarded to the man and woman with the most votes at the end of ten weeks; the top local fundraisers in the country win the national titles.

Man & Woman candidates are goal-oriented and compassionate. Their relentless efforts are focused on making life better for hundreds of thousands of patients battling blood cancers: leukemia, lymphoma and myeloma.

Vote for Dr. Lawenda. Read a message from Dr. Lawenda below.

Please join myself and 21st Century Oncology in supporting The Leukemia & Lymphoma Society (LLS) by making a donation to my fundraising campaign. Every dollar I raise counts as one vote and the candidate who gets the most votes /raises the most money is named the Man or Woman of the Year.

The picture below is Kennedy, she was nominated as the “Girl of the Year” here in Las Vegas. She is beating Acute Lymphocytic Leukemia (A.L.L.). This amazing little girl serves as inspiration and motivation for the hard working candidates running for Man & Woman of the Year, including myself.

Thanks to your support, my efforts, will help fund the therapies and treatments and help patients such as Kennedy get the care she needs to continue beating her disease.

LLS’s continued advancements over the years, are responsible for the blood cancer survival rate doubling and tripling; in some cases, the survival rate has even quadrupled.

And many LLS supported therapies not only help blood cancer patients but are now used to treat patients with rare forms of stomach and skin cancers. They’re even being tested in clinical trials for patients with a range of cancers including lung, brain, breast, pancreatic and prostate cancers. LLS funded drugs like Gleevec, Sprycel, Arinza, Tasigna and Zolinza are now being tested for patients with other non-cancerous diseases like Diabetes, Rheumatoid Arthritis and Multiple Sclerosis.

We really are changing the face of blood cancer!

All donations are greatly appreciated and are tax deductible. They’ll not only support LLS research but patient services, advocacy, public and professional education, and community services as well.

Please visit my Web site often and bring friends who would also like to donate!

On behalf of blood cancer patients everywhere I thank you for your support! For more information about LLS, please visit www.lls.org

Thank you for your support!

Brian D. Lawenda, M.D.
Clinical Director, Radiation Oncology
21st Century Oncology (Las Vegas)